« Previous Next » Urology
Volume 72, Issue 2 , Pages 241-242 , August 2008

Reply

Taro Iguchi, M.D., Ph.D.
- Department of Urology, State University of New York Upstate Medical University, Syracuse, New York and Department of Urology, Osaka City University School of Medicine, Osaka, Japan
Ching Y. Wang, D.V.M., Ph.D.
- Department of Urology, State University of New York Upstate Medical University, Syracuse, New York
Nicolas B. Delongchamps, M.D.
- Department of Urology, State University of New York Upstate Medical University, Syracuse, New York
Gabriel P. Haas, M.D.
- Department of Urology, State University of New York Upstate Medical University, Syracuse, New York
Tatsuya Nakatani, M.D., Ph.D.
- Department of Urology, Osaka City University, School of Medicine, Osaka, Japan
Robert Sunheimer, M.S.
- Department of Pathology, State University of New York Upstate Medical University, Syracuse, New York
Gustavo de la Roza, M.D.
- Department of Pathology, State University of New York Upstate Medical University, Syracuse, New York

References

Bates AS, Margolis PA, Evans AT. Verification bias in pediatric studies evaluating diagnostic tests. J Pediatr. 1993;122:585–590
Punglia RS, D'Amico AV, Catalona WJ, et al. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med. 2003;349:335–342
- CrossRef
Haas GP, Delongchamps NB, Jones RF, et al. Needle biopsies on autopsy prostates: Sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst. 2007;99:1484–1489
- CrossRef
Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med. 2004;350:2239–2246
- CrossRef